Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Gland Pharma Ltd. ( (IN:GLAND) ) just unveiled an announcement.
Gland Pharma Limited has announced a change in the contact details of its Registrar and Share Transfer Agent (RTA) due to a rebranding from ‘Link Intime India Private Limited’ to ‘MUFG Intime India Private Limited’. This update is crucial for shareholders and stakeholders who need to interact with the RTA for queries or service requests, ensuring continued smooth operations and communication.
More about Gland Pharma Ltd.
Gland Pharma Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of complex injectables. The company is known for its wide range of products that cater to various therapeutic areas, serving both domestic and international markets.
YTD Price Performance: -18.25%
Average Trading Volume: 14,139
Current Market Cap: 238.9B INR
See more insights into GLAND stock on TipRanks’ Stock Analysis page.